Supreet Deshpande, MD & President, US subsidiary- NovaLead Pharma Inc addresses during the announcement of successful completion of global phase I /II clinical trial for Galnobax®: a topical gel for treatment of Diabetic Foot Ulcer (DFU) in Mumbai on Tuesday, 03 November 2015.
Tags: Managing Director at NovaLead PharmaPresident at US subsidiary- NovaLead Pharma Incvertical
Credit balance: 0